Identification of external opportunities to strengthen client’s portfolio in Emerging Markets
A global pharmaceutical company approached SmartAnalyst to help improve its portfolio of external opportunities within emerging markets. SmartAnalyst took up the challenge to develop a list of attractive indications within the GI, Oncology, and Diabetes therapy areas.
SmartAnalyst utilized a two-phased approach to identify potential assets for each therapy area. Through identification and shortlisting of assets, SmartAnalyst was able to prioritize each asset based on pre-defined criteria and client strategic considerations.
Read the full case study here.
Jump to a slide with the slide dots.
Assessing the market for a novel gene therapy
Our client was preparing for the launch of a novel gene therapy and was looking to understand the potential value of its product in the market.
Read moreAssessing the commercial potential of an asset in Tourette’s Syndrome
SmartAnalyst was set the task to evaluate the commercial opportunity for a potential asset in Tourette’s Syndrome.
Read more